Studies have shown that active fund managers routinely underperform the S&P500 index*​

Minerva Neurosciences, Inc. (NASDAQ: NERV)

NERV Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
BUY
Analyst Forecast (1yr):
87%

NERV Stock Analysis

NERV PE Ratio:

NERV PEG Ratio: Not Available

NERV Forward EPS Growth (12 month): 0.00%

NERV PS Ratio:

NERV PSG Ratio: Not Available

NERV Forward Revenue Growth (12 month): 0.00%

NERV Articles

No data was found